Skip to main content
Erschienen in: Journal of Cancer Education 4/2020

08.07.2020 | Editorial

20 Years Later: Continued Relevance of Cancer, Culture, and Literacy in Cancer Education for Social Justice and Health Equity

verfasst von: Cathy D. Meade, Nathanael B. Stanley, Dinorah Martinez-Tyson, Clement K. Gwede

Erschienen in: Journal of Cancer Education | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Excerpt

The persistence of health disparities is no longer a novel observation, but a well-documented reality whereby many populations have markedly unrelenting poorer levels of health. Inequities are influenced by complex historical and contemporary relationships between health and biology, and further affected by racism, discrimination, socioeconomic status, physical environment, literacy, and sexual orientation/gender identity to name a few [1, 2]. Recognition of such factors is essential for a norm of inclusion for achieving health equity [3]. As society globalizes through technological innovations and migration of populations, increasing prominence of cultural- and literacy-based research opportunities evolves in the field of cancer education. Crucially important is a need to assess, recognize, and address the effect of changing trends and recent events on cancer health disparities. In this editorial, we highlight the continued relevance of culture and health literacy in cancer education, and the promising opportunity that technology may play to advance health equity and social justice. …
Literatur
3.
5.
Zurück zum Zitat Kagawa-Singer M, Dressler W, George SM, Elwood WN (2014) The cultural framework for health: an integrative approach for research and program design and evaluation. National Institutes of Health, Office of Behavioral and Social Sciences Research Kagawa-Singer M, Dressler W, George SM, Elwood WN (2014) The cultural framework for health: an integrative approach for research and program design and evaluation. National Institutes of Health, Office of Behavioral and Social Sciences Research
6.
Zurück zum Zitat Institute of Medicine, Committee on Health Literacy. 2004. Culture and society. In Health literacy: a prescription to end confusion, eds. David A. Kindig, and Allison M. Panzer, and Lynn Nielsen-Bohlman. National Academies Press. Institute of Medicine, Committee on Health Literacy. 2004. Culture and society. In Health literacy: a prescription to end confusion, eds. David A. Kindig, and Allison M. Panzer, and Lynn Nielsen-Bohlman. National Academies Press.
8.
Zurück zum Zitat Ratzan, S.C., .LO. Gostin, N. Meshkati, K. Rabin, and R.M. Parker. 2020. COVID-19: an urgent call for coordinated, trusted sources to tell everyone what they need to know and do. NAM Perspectives. Ratzan, S.C., .LO. Gostin, N. Meshkati, K. Rabin, and R.M. Parker. 2020. COVID-19: an urgent call for coordinated, trusted sources to tell everyone what they need to know and do. NAM Perspectives.
9.
Zurück zum Zitat Freeman HP (2004) Poverty, culture, and social injustice: determinants of cancer disparities. CA Cancer J Clin 54(2):72–77CrossRef Freeman HP (2004) Poverty, culture, and social injustice: determinants of cancer disparities. CA Cancer J Clin 54(2):72–77CrossRef
10.
Zurück zum Zitat Regnante JM, Richie NA, Fashoyin-Aje L, Vichnin M, Ford M, Roy UB, Turner K, Hall LL, Gonzalez E, Esnaola N, Clark LT, Adams HC III, Alese OB, Gogineni K, McNeill L, Petereit D, Sargeant I, Dang J, Obasaju C, Highsmith Q, Lee SC, Hoover SC, Williams EL, Chen MS Jr (2019) US cancer centers of excellence strategies for increased inclusion of racial and ethnic minorities in clinical trials. J Oncol Pract 15(4):e289–e299. https://doi.org/10.1200/JOP.18.00638 CrossRefPubMed Regnante JM, Richie NA, Fashoyin-Aje L, Vichnin M, Ford M, Roy UB, Turner K, Hall LL, Gonzalez E, Esnaola N, Clark LT, Adams HC III, Alese OB, Gogineni K, McNeill L, Petereit D, Sargeant I, Dang J, Obasaju C, Highsmith Q, Lee SC, Hoover SC, Williams EL, Chen MS Jr (2019) US cancer centers of excellence strategies for increased inclusion of racial and ethnic minorities in clinical trials. J Oncol Pract 15(4):e289–e299. https://​doi.​org/​10.​1200/​JOP.​18.​00638 CrossRefPubMed
11.
Zurück zum Zitat Niranjan SJ, Durant RW, Wenzel JA, Cook ED, Fouad MN, Vickers SM, Konety BR, Rutland SB, Simoni ZR, Martin MY (2019) Training needs of clinical and research professionals to optimize minority recruitment and retention in cancer clinical trials. J Cancer Educ 34(1):26–34CrossRef Niranjan SJ, Durant RW, Wenzel JA, Cook ED, Fouad MN, Vickers SM, Konety BR, Rutland SB, Simoni ZR, Martin MY (2019) Training needs of clinical and research professionals to optimize minority recruitment and retention in cancer clinical trials. J Cancer Educ 34(1):26–34CrossRef
12.
Zurück zum Zitat Lippman SM, Abate-Shen C, Maresso KL, Colditz GA, Dannenberg AJ, Davidson NE, Disis ML, DuBois RN, Szabo E, Giuliano AR (2018) AACR White Paper: shaping the future of cancer prevention–a roadmap for advancing science and public health. Cancer Prev Res 11(12):735–778CrossRef Lippman SM, Abate-Shen C, Maresso KL, Colditz GA, Dannenberg AJ, Davidson NE, Disis ML, DuBois RN, Szabo E, Giuliano AR (2018) AACR White Paper: shaping the future of cancer prevention–a roadmap for advancing science and public health. Cancer Prev Res 11(12):735–778CrossRef
14.
Zurück zum Zitat U.S. Department of Health and Human Services. 2011. HHS action plan to reduce racial and ethnic disparities: a nation free of disparities in health and health care: U.S. Department of Health and Human Services. U.S. Department of Health and Human Services. 2011. HHS action plan to reduce racial and ethnic disparities: a nation free of disparities in health and health care: U.S. Department of Health and Human Services.
Metadaten
Titel
20 Years Later: Continued Relevance of Cancer, Culture, and Literacy in Cancer Education for Social Justice and Health Equity
verfasst von
Cathy D. Meade
Nathanael B. Stanley
Dinorah Martinez-Tyson
Clement K. Gwede
Publikationsdatum
08.07.2020
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 4/2020
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-020-01817-y

Weitere Artikel der Ausgabe 4/2020

Journal of Cancer Education 4/2020 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.